Fri.Aug 30, 2024

article thumbnail

STAT+: Wegovy cut patients’ chances of dying from Covid-19, new analysis shows

STAT

LONDON — Novo Nordisk made worldwide headlines last year when a study demonstrated that Wegovy, its powerful and exceedingly popular weight loss medicine, helped reduce the risk of cardiovascular emergencies like heart attacks.  Researchers on Friday unveiled results demonstrating another benefit that the drug offered to patients in that study: Compared to placebo, it cut the chances of dying from Covid-19 by roughly a third.

article thumbnail

The Importance of Reaching Out: Why Talking to Someone Matters

Pharmacy Is Right For Me

As the school year begins, students often find themselves juggling a variety of responsibilities—homework, extracurricular activities, social commitments, and more. For those with aspirations in the demanding field of pharmacy, the pressure to excel can sometimes feel overwhelming. During these moments, it’s essential to remember that you don’t have to navigate challenges alone.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Los Angeles County: the epicenter of urban maternity ward closings

STAT

LOS ANGELES — Simone DeRoche, expecting her fourth child in December, had her birth plan set: delivering at USC Verdugo Hills Hospital, where her three other kids were born.  But when she received the text from her OB-GYN last week that the hospital will be closing its maternity ward and NICU in November, DeRoche felt a wave of disappointment and sadness.

Hospitals 313
article thumbnail

SAEM Clinical Images Series: Pediatric Neck Mass

ALiEM - Pharm Pearls

A 5-year-old female presented to the emergency department (ED) with a one-year history of gradually increasing anterior neck swelling. The patient had no significant past medical history. She also endorsed three weeks of cough and congestion, and one day of muffled voice. She denied difficulty swallowing, fatigue, cold intolerance, or hair and nail changes.

161
161
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

STAT+: Detailed data on Alnylam’s heart drug show substantial benefit, while competition likely awaits

STAT

LONDON — An experimental drug from Alnylam Pharmaceuticals substantially cut the risk of death and serious cardiovascular complications among patients with an increasingly diagnosed heart disease, likely teeing up the medicine to be a new option for patients, but one that will face competition from another treatment also nearing potential approval.

309
309
article thumbnail

Is anyone taking the world’s priciest drugs?

PharmaVoice

A slew of breakthrough gene therapies won FDA approval in recent years — but high price tags haven’t always yielded big returns.

130
130

More Trending

article thumbnail

South East London pharmacies get increased patient record access

The Pharmacist

Several community pharmacies in South East London have now been given access to the London Care Record – providing a ‘single and secure’ view of patient information across health and social care. They join community pharmacies in North East London and South West London, as well as other primary, secondary and community care providers across […] The post South East London pharmacies get increased patient record access appeared first on The Pharmacist.

article thumbnail

STAT+: New Wegovy analysis could boost Novo Nordisk’s bid to expand drug’s label in heart failure

STAT

Novo Nordisk’s obesity drug Wegovy cut the risk of severe complications in patients with a common form of heart failure, according to a new analysis that could boost the company’s efforts to expand the label for the blockbuster treatment. Researchers combined data on nearly 4,000 patients across four trials who had heart failure with reduced ejection fraction (or HFpEF) and found that 5.4% of those treated with Wegovy experienced cardiovascular-related death or heart failure events

Labelling 279
article thumbnail

Emergent Bio gets FDA green light for mpox vaccine

pharmaphorum

Emergent BioSolutions has been given FDA approval to extend the indications for its smallpox vaccine ACAM2000 to include the prevention of mpox, currently deemed a public health emergency by the WHO.

Vaccines 100
article thumbnail

STAT+: Pharmalittle: We’re reading about Wegovy study results, an Alnylam heart drug, and more

STAT

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda, so far, is rather modest. We plan to promenade with the official mascots, spend time with our Pharmalot ancestor, and catch up on our reading. With any luck, we will also find time for another listening party, where the rotation is likely to include this , this , this , this and this.

Hospitals 261
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

Are PBMs to blame for high drug prices in the US?

Pharmaceutical Technology

US Congress labelled pharmacy benefit managers (PBMs) as ‘anticompetitive’; PBMs blame manufacturers for increasing pharmaceutical prices.

article thumbnail

Monica from ‘Friends’, RFK Jr., and how many ‘r’s are in ‘strawberry’

STAT

Want to stay on top of health news?  Sign up  to get our Morning Rounds newsletter in your inbox. I just returned from a lovely two-week remote work/vacation trip to Oregon and this meme is my mood today.

203
203
article thumbnail

Full study data back Alnylam heart drug’s benefit, but leave doctors with tough choices

BioPharma Dive

Detailed results from the Helios-B study support summary findings disclosed in June. But they may not make vutrisiran the standard of care as easily as Alnylam hopes.

83
article thumbnail

Bayer and NextRNA Therapeutics enter strategic collaboration to develop small molecules targeting long non-coding RNAs (lncRNAs) in oncology

World Pharma News

Bayer and NextRNA Therapeutics, a biotechnology company focused on developing transformative medicines to address long non-coding RNA (lncRNA)-driven diseases, have entered into a collaboration and license agreement to develop small molecule therapeutics targeting lncRNAs in oncology. lncRNAs represent a vast class of therapeutic targets that recruit RNA-binding proteins (RBPs) to drive pathological processes across diseases.

89
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

COPD diagnosed prevalent cases across 7MM to reach 38.02 million in 2033, forecasts GlobalData

Express Pharma

The diagnosed prevalent cases of chronic obstructive pulmonary disease (COPD) in the seven major markets (7MM*) are set to register an annual growth rate (AGR) of 1.27 per cent from 33.74 million in 2023 to 38.02 million in 2033, forecasts GlobalData. GlobalData’s latest report, “Chronic Obstructive Pulmonary Disease – Epidemiology Forecast to 2033,” reveals that the US will have the highest number of diagnosed prevalent cases of COPD among the 7MM at 17.88 million cases, whereas Spain will have

Dosage 83
article thumbnail

UK biotech ReNeuron quits AIM as financing push fails

pharmaphorum

Troubled UK biotech ReNeuron will cancel its AIM listing, saying it has been unable to raise the funds it needs to bring it out of administration

95
article thumbnail

Zydus Lifesciences receives U.S. FDA approval for Scopolamine Transdermal System

Express Pharma

Zydus Lifesciences (including its subsidiaries/ affiliates, hereafter referred to as “Zydus”) has received final approval from the United States Food and Drug Administration (USFDA) to market Scopolamine Transdermal System 1 mg/3 days. (USRLD: Transderm Scop Transdermal System 1 mg/3 days). This is the fifth ANDA approval for Zydus in the transdermal portfolio, leveraging the group’s strengths in the manufacturing of complex drug device dosage forms.

Dosage 77
article thumbnail

How the Life Sciences Innovative Manufacturing Fund can boost funding for pharma

pharmaphorum

Discover how the Life Sciences Innovative Manufacturing Fund can help boost funding for pharmaceutical companies. Learn how this fund can support innovation and growth in the life sciences sector.

article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

CDSCO reports low failure rate in cough syrup testing amid enhanced supply chain monitoring

Express Pharma

CDSCO reports low failure rate in cough syrup testing amid enhanced supply chain monitoring o ver 8,000 batches tested since July 2023, with only 2-3% failure rate; CDSCO strengthens regulatory measures ahead of winter season. The Central Drugs Standard Control Organisation (CDSCO) has reported a low failure rate of just 2-3 per cent in recent cough syrup testing of more than 8,000 batches.

article thumbnail

Suicide rates highest seen in 25 years, official figures show

The Pharmacist

Suicide should be treated as a public health crisis, a charity has warned after figures from the Office for National Statistics showed the highest rate since 1999. Official figures show there were 6,069 suicides registered in England and Wales in 2023, compared with 5,642 the previous year. It equates to 11.4 deaths per 100,000 people […] The post Suicide rates highest seen in 25 years, official figures show appeared first on The Pharmacist.

63
article thumbnail

Novo builds heart failure case for semaglutide; Ventyx CFO departs

BioPharma Dive

A new analysis showed semaglutide reduced the risk of worsening heart failure. Elsewhere, the FDA approved a vaccine for mpox and a biotech planned layoffs.

article thumbnail

Johnson & Johnson seeks FDA approval for generalised myasthenia gravis therapy

Pharmaceutical Business Review

The application is supported by findings from the Phase III Vivacity-MG3 clinical trial. Assessing the improvement in the MG-ADL score from baseline over 24 weeks was the primary endpoint of the study. Study participants included adults positive for anti-AChR, anti-MuSK, and anti-LRP4 antibodies, representing approximately 95% of the gMG patient population.

59
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

BioMarin's change in direction claims more jobs

pharmaphorum

BioMarin wields axe again, slashing 225 positions from its global workforce as it continues a major restructuring drive

84
article thumbnail

Pharma Pulse 8/30/24: Medication Mistakes Pharmacists Want You to Stop Making, Express Scripts to Remove Humira & more

Pharmaceutical Commerce

The latest news for pharma industry insiders.

103
103
article thumbnail

CD44 Antigen drugs in development, 2024

Pharmaceutical Technology

GlobalData’s report assesses the drugs in the CD44 Antigen pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline.

52
article thumbnail

Is Poison Control Pharmacy Right For You?

The Happy PharmD

Imagine a pharmacy career where every moment could be life and death. Well, that’s the reality for poison control pharmacists in toxicology. They handle everything from 12-hour shifts to being on call, all while sometimes not earning as much as their peers in other pharmacy sectors. Despite these challenges, it’s a deeply fulfilling path.

article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

How GEP Helped a Global Fresh Produce Company Unlock Millions in Savings

Pharma and Life Sciences Blog

How GEP Helped a Global Fresh Produce Company Unlock Millions in Savings annmarie@AZglo… Fri, 08/30/2024 - 23:13 For companies dealing in fresh produce, even small disruptions in supply chain efficiency can result in significant financial setbacks. A Fortune 500 company learned this the hard way, when it faced €12.2 million in potential losses from supply-demand mismatch.

52
article thumbnail

Johnson & Johnson Submits Biologics License Application for Nipocalimab in Patients with Antibody-Positive Generalized Myasthenia Gravis

PharmExec

Submission is supported by results from the Phase III Vivacity-MG3 study, which demonstrated that nipocalimab, combined with standard care, significantly improved outcomes for patients with antibody-positive generalized myasthenia gravis.

52
article thumbnail

Sustainable PFAS-free synthesis for pharmaceutical compounds

European Pharmaceutical Review

Researchers have developed an innovative synthesis method for pharmaceutical compounds that does not require the use of PFAS reagents. Caesium fluoride salt was used as alternative fluorine source. The approach resulted in a combination of various anions with a range of substrates which produced multiple fluorinated products with relevance to pharmaceutical syntheses, according to the team.

article thumbnail

Back-to-School Health Checklist: Preparing Your Kids for a Healthy School Year

Community Pharmacy

As we roll through August and toward September, it’s time to make an annual back-to-school health checklist so your children start the new semester off on a healthy, strong foot. Compared to the often lackadaisical, long summer days, getting back into the rhythm of a more structured schedule can be a challenge for children and parents alike. Luckily, by covering a few basic bases, and setting and holding to new schedules and health practices, most of these issues can be avoided easily enou

article thumbnail

Cholecystokinin Receptor Type A drugs in development, 2024

Pharmaceutical Technology

GlobalData’s report assesses the drugs in the Cholecystokinin Receptor Type A pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline.

52